Evidence map›Paper›PMID 28824055›Full record

Trial reportInternal medicine (Tokyo, Japan)2017

Bronchodilator Effect of Tiotropium via Respimat

Takashi Ogasawara, Jun Sakata, Yoichiro Aoshima, Kazuki Tanaka, Toshiaki Yano, Norio Kasamatsu

Open access · diamondAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Internal medicine (Tokyo, Japan), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Takashi OgasawaraDepartment of Respiratory Medicine, Hamamatsu Medical Center, Japan.
Jun SakataPharmaceutical Department, Hamamatsu Medical Center, Japan.
Yoichiro AoshimaDepartment of Respiratory Medicine, Hamamatsu Medical Center, Japan.
Kazuki TanakaDepartment of Respiratory Medicine, Hamamatsu Medical Center, Japan.
Toshiaki YanoDepartment of Respiratory Medicine, Hamamatsu Medical Center, Japan.
Norio KasamatsuDepartment of Respiratory Medicine, Hamamatsu Medical Center, Japan.
Hamamatsu Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective Among elderly patients with chronic obstructive pulmonary disease (COPD), there are some patients who cannot inhale tiotropium via Respimat

Indexed as

Nebulizers and VaporizersAdministration, InhalationAgedBronchodilator AgentsCross-Over StudiesFemaleForced Expiratory VolumeHumansMaleMiddle AgedProspective StudiesPulmonary Disease, Chronic ObstructiveRespiratory Function TestsTerbutalineTiotropium BromideBronchodilator AgentsTerbutalineTiotropium Bromidetulobuterolchronic obstructive pulmonary diseaseRespimat®spacertiotropium

Identifiers

PMID28824055
PMCPMC5643165
OpenAlexW2749755551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.